Monday, July 7, 2025 7/7/2025

Delaware Clinical and Translational Research ACCEL Program

Award Number: U54GM104941
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/25/2013
PERIOD OF PERFORMANCE END DATE: 06/30/2028

Group Awards By:

View Award Description

Delaware Clinical and Translational Research ACCEL Program - ABSTRACT- OVERALL This proposal is a competitive renewal of the Institutional Development Award Program Infrastructure for Clinical and Translational Research (IDeA-CTR)(U54) grant originally awarded in September 2013 to the University of Delaware. The ACCEL CTR Program, has completed nine years of funding at the time of this application. During our third funding cycle (ACCEL3), our consortium will consist of four partners: University of Delaware (UD)—the lead institution; Nemours Children’s Health (Nemours); Christiana Care Health System (CCHS), the largest health care system in Delaware; and Delaware State University (DSU), an American historically Black, public university that joined our consortium during the last competitive renewal. Over the past nine years, ACCEL has established an exceedingly strong network and infrastructure for clinical and translational (C&T) research within the state of Delaware; and, we are now poised and ready to continue our growth trajectory. While we will continue with the activities that have made us successful, we will have a sharper focus on building sustainable infrastructure across the state that can continue to thrive and mature for years to come. And, we will focus on creating a scientific culture focused, not only, on improving the health of Delawareans, but doing so through a lens of health equity. In our mission to establish a cadre of successful C&T scientists in DE, we will use various approaches to promote full consideration of how their work impacts the needs of all members of society, from design to study implementation to dissemination of findings. And, we will have a much greater focus on building a bi-directional relationship between our scientists and the community so that we can have a greater impact on Delawareans. Delaware is an ideal state for a CTR grant as it represents the whole of the USA in a compact form. The population of Delaware (~970,000) mirrors the US population in urban-to-rural citizen ratio and ethnic/racial diversity, with 23% African American, 62% Caucasian, 10% Hispanic, 4% Asian and 1% Native American. Thus, studies involving a cross-section of Delaware can be generalizable to populations nationally. The dominance of adult (CCHS) and pediatric (Nemours) hospital systems, which serve at least 85% of the residents of the state, provides a unique opportunity to treat the state of Delaware as a model for examining how healthcare changes can impact population health. The overarching goal of the ACCEL CTR Program is to create a unified Delaware Clinical and Translational Research Community (inclusive of investigators and community members) that breaks down existing barriers, capitalizes on the unique strengths of its partners to establish infrastructure and accelerates the creation of equitable solutions that improve the health of all Delawareans and all Americans.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $4,368,809 )
2024	2024	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	004	12	8/22/2024	NON-COMPETING CONTINUATION	$3,973,253
2024	2024	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	005	12	8/29/2024	SUPPLEMENT FOR EXPANSION	$395,556
2024	2023	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	000	11	2/7/2024	COMPETING CONTINUATION	$0
2024	2023	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	003	11	3/13/2024	COMPETING CONTINUATION	$1,920,772
2024	2022	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	001	10	3/13/2024	NON-COMPETING CONTINUATION	-$1,834,833
2024	2022	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	002	10	3/13/2024	SUPPLEMENT FOR EXPANSION	-$85,939
														Subtotal = $4,368,809

Issue Date FY: 2023 ( Subtotal = $4,601,068 )
2023	2023	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	002	11	7/21/2023	COMPETING CONTINUATION	$4,000,000
2023	2023	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	003	11	8/21/2023	COMPETING CONTINUATION	$0
2023	2023	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	006	11	8/29/2023	SUPPLEMENT FOR EXPANSION	$90,315
2023	2023	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	004	11	8/21/2023	SUPPLEMENT FOR EXPANSION	$301,644
2023	2023	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	005	11	8/23/2023	SUPPLEMENT FOR EXPANSION	$209,109
2023	2022	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	000	10	11/3/2022	NON-COMPETING CONTINUATION	$0
2023	2022	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	001	10	7/21/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $4,601,068

Issue Date FY: 2022 ( Subtotal = $4,187,345 )
2022	2022	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	002	10	7/22/2022	SUPPLEMENT FOR EXPANSION	$187,350
2022	2022	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	001	10	7/19/2022	NON-COMPETING CONTINUATION	$3,999,995
2022	2021	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	000	9	11/8/2021	NON-COMPETING CONTINUATION	$0
														Subtotal = $4,187,345

Issue Date FY: 2021 ( Subtotal = $4,683,067 )
2021	2021	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	003	9	7/6/2021	SUPPLEMENT FOR EXPANSION	$287,168
2021	2021	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	002	9	6/24/2021	NON-COMPETING CONTINUATION	$3,999,998
2021	2021	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	004	9	7/12/2021	SUPPLEMENT FOR EXPANSION	$395,901
2021	2021	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	005	9	7/16/2021	SUPPLEMENT FOR EXPANSION	$0
2021	2021	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	006	9	8/13/2021	NON-COMPETING CONTINUATION	$0
2021	2020	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	001	8	3/18/2021	NON-COMPETING CONTINUATION	$0
2021	2020	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	000	8	2/2/2021	NON-COMPETING CONTINUATION	$0
														Subtotal = $4,683,067

Issue Date FY: 2020 ( Subtotal = $4,154,041 )
2020	2020	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	000	8	7/24/2020	NON-COMPETING CONTINUATION	$3,999,997
2020	2020	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	001	8	8/24/2020	SUPPLEMENT FOR EXPANSION	$154,044
														Subtotal = $4,154,041

Issue Date FY: 2019 ( Subtotal = $3,999,996 )
2019	2019	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	005	7	8/30/2019	NON-COMPETING CONTINUATION	$0
2019	2019	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	004	7	8/2/2019	NON-COMPETING CONTINUATION	$3,999,996
2019	2018	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	003	6	6/19/2019	COMPETING CONTINUATION	$0
2019	2018	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	002	6	6/12/2019	COMPETING CONTINUATION	$1,127,051
2019	2018	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	000	6	11/9/2018	COMPETING CONTINUATION	$0
2019	2017	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	001	5	6/12/2019	NON-COMPETING CONTINUATION	-$1,127,051
														Subtotal = $3,999,996

Issue Date FY: 2018 ( Subtotal = $4,298,873 )
2018	2018	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	004	6	9/7/2018	SUPPLEMENT FOR EXPANSION	$298,875
2018	2018	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	003	6	9/5/2018	COMPETING CONTINUATION	$3,999,998
2018	2017	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	002	5	9/4/2018	NON-COMPETING CONTINUATION	$0
2018	2016	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	001	4	10/27/2017	EXTENSION WITH OR WITHOUT FUNDS	$18,860
2018	2015	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	000	3	10/27/2017	NON-COMPETING CONTINUATION	-$18,860
														Subtotal = $4,298,873

Issue Date FY: 2017 ( Subtotal = $3,942,936 )
2017	2017	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	000	5	6/15/2017	NON-COMPETING CONTINUATION	$3,942,936
														Subtotal = $3,942,936

Issue Date FY: 2016 ( Subtotal = $3,978,029 )
2016	2016	UNIVERSITY OF DELAWARE	210 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	000	4	7/7/2016	EXTENSION WITH OR WITHOUT FUNDS	$3,978,029
														Subtotal = $3,978,029

Issue Date FY: 2015 ( Subtotal = $3,982,401 )
2015	2015	UNIVERSITY OF DELAWARE	210 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	000	3	6/9/2015	NON-COMPETING CONTINUATION	$3,982,401
														Subtotal = $3,982,401

Issue Date FY: 2014 ( Subtotal = $3,988,453 ) (Continued on the next page)
Grand Total All Awards = $50,158,198

Page 1 of 2 (53 items)12

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Delaware Clinical and Translational Research ACCEL Program

Award Number: U54GM104941

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/25/2013

PERIOD OF PERFORMANCE END DATE: 06/30/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer